↑ トップへ　← 戻る

 Drug（薬物リスト） DrugBank | All Description Patterns

   e.g. "Sirolimus", "アダリムマブ"

A　B　C　D　E　F　G　H　 I 　J　K　L　M　N　O　P　Q　R　S　T　U　V　W　X　Y　Z　other

887 / 12,170 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名（臨床試験情報から抽出）   DrugBank   KEGG DRUG *   KEGG GENES *   KEGG PATHWAY   指定難病告示番号 * 
 1   (-)-3-(4-aminophenyl)-2-methoxypropionic acid   -   -   -   -   1件:
97 
 2   (r)-3-(1-oxo-propoxy)-4-(n,n,n-trimethyl amonium chloride)-butanoic acid   Butyric acid   D05866   -   -   1件:
97 
 3   (s)-(-)-3-(4-aminophenyl)-2-methoxypropionic acid   -   -   -   -   1件:
97 
 4   (s)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1h-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile hydrochloride   -   -   -   -   1件:
97 
 5   -aminosalicylic acid   Aminosalicylic acid   D00162   -   -   2件:
96,
97 
 6   0.25 mg rpc1063   -   -   -   -   2件:
96,
97 
 7   0.25mg rpc103   -   -   -   -   1件:
97 
 8   0.5 mg rpc1063   -   -   -   -   1件:
97 
 9   1 mg rpc1063   -   -   -   -   1件:
97 
 10   1.0 mg rpc103   -   -   -   -   1件:
97 
 11   1.0 mg rpc1063   -   -   -   -   1件:
97 
 12   1.remicade   Infliximab   D02598   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   1件:
97 
 13   10 mg natura-alpha capsule   -   -   -   -   1件:
97 
 14   100 mg   -   -   -   -   1件:
97 
 15   150 mg   -   -   -   -   1件:
97 
 16   1500mg mesalazine pellets   Mesalazine   D00377   -   -   1件:
97 
 17   15n2-tofacitinib   Tofacitinib   D09970   4件: JAK1, JAK2, JAK3, TYK2   34件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis   1件:
97 
 18   2 x 10 mg natura-alpha capsules   -   -   -   -   1件:
97 
 19   2'-fucosyllactose   -   -   -   -   2件:
96,
97 
 20   2-hydroxybenzoic acid   Salicylic acid   D00097   -   -   1件:
97 
 21   20 mg   -   -   -   -   1件:
97 
 22   225mg pf-00547659   -   -   -   -   1件:
97 
 23   23-valent polysaccharide pneumococcal vaccine (pneumovax tm)   -   -   -   -   2件:
96,
97 
 24   250mg mesalazine pellets   Mesalazine   D00377   -   -   1件:
97 
 25   2l polyethylene glycol/ascorbic acid   Polyethylene glycol   D03370   -   -   1件:
97 
 26   331731-18-1   -   -   -   -   2件:
46,
97 
 27   40 mg msb11022   -   -   -   -   4件:
46,
96,
97,
271 
 28   42942019   -   -   -   -   4件:
46,
96,
97,
271 
 29   450 mg   -   -   -   -   1件:
97 
 30   5 asa   Mesalazine   D00377   -   -   1件:
97 
 31   5 asa, enemas, suppositories, corticosteroids   Mesalazine   D00377   -   -   1件:
97 
 32   5-amino salicylic acid   Salicylic acid   D00097   -   -   1件:
97 
 33   5-amino salicylic acid (5-asa)   Salicylic acid   D00097   -   -   1件:
97 
 34   5-amino-2-hydroxybenzoic acid   Salicylic acid   D00097   -   -   1件:
97 
 35   5-aminosalicyclic acid   -   -   -   -   1件:
97 
 36   5-aminosalicylate   Mesalazine   D00377   -   -   2件:
96,
97 
 37   5-aminosalicylate (pentasa, ferring)   Mesalazine   D00377   -   -   2件:
96,
97 
 38   5-aminosalicylic acid   Aminosalicylic acid   D00162   -   -   2件:
96,
97 
 39   5-aminosalicylic acid (5-asa)   Aminosalicylic acid   D00162   -   -   1件:
97 
 40   5-aminosalicylic acid(5-asa) and/or prednisone   Aminosalicylic acid   D00162   -   -   1件:
97 
 41   5-asa   Mesalazine   D00377   -   -   2件:
96,
97 
 42   5-asa (5-aminosalicylate)   Mesalazine   D00377   -   -   1件:
97 
 43   5-asa mmx   Mesalazine   D00377   -   -   1件:
97 
 44   5-htp   -   -   -   -   2件:
96,
97 
 45   50 mg   -   -   -   -   1件:
97 
 46   500 mg lx1606 qd   -   -   -   -   1件:
97 
 47   500 mg lx1606 tid   -   -   -   -   1件:
97 
 48   500mg mesalazine pellets   Mesalazine   D00377   -   -   1件:
97 
 49   549-0261/f02-01   -   -   -   -   2件:
96,
97 
 50   5asa   Mesalazine   D00377   -   -   1件:
97 
 51   6 mercaptopurine   Mercaptopurine   D00161, D04931   1件: HPRT1   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   2件:
96,
97 
 52   6-[2-(3,4-diethoxyphenyl)thiazol-4-yl] pyridine-2-carboxylic acid   -   -   -   -   1件:
97 
 53   6-mercaptopurine   Mercaptopurine   D00161, D04931   1件: HPRT1   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   2件:
97,
164 
 54   6-mp   Mercaptopurine   D00161, D04931   1件: HPRT1   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   2件:
96,
97 
 55   750mg mesalazine pellets   Mesalazine   D00377   -   -   1件:
97 
 56   75mg pf-00547659   -   -   -   -   1件:
97 
 57   [124i]ib pf 06687234   -   -   -   -   1件:
97 
 58   [14c]-rpc1063 solution (0.1 mg/ml) for oral administration   -   -   -   -   3件:
13,
96,
97 
 59   [18f]fspg   -   -   -   -   2件:
96,
97 
 60   A multistrain probiotic product (dsf)   -   -   -   -   1件:
97 
 61   A: 1 dosis   -   -   -   -   1件:
97 
 62   Ab (antibiotics)   -   -   -   -   1件:
97 
 63   Abalimumab   -   -   -   -   1件:
97 
 64   Abatacept   Abatacept   D03203   2件: CD80, CD86   12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis   24件:
11,
13,
19,
41,
44,
46,
49,
50,
51,
53,
55,
60,
65,
84,
93,
96,
97,
107,
164,
222,
271,
284,
285,
300 
 65   Abatacept (aba)   Abatacept   D03203   2件: CD80, CD86   12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis   1件:
97 
 66   Abbv-006   -   -   -   -   1件:
97 
 67   Abbv-066   -   -   -   -   2件:
96,
97 
 68   Abbv-323 dose a   -   -   -   -   1件:
97 
 69   Abbv-323 dose b   -   -   -   -   1件:
97 
 70   Abgn-168h   -   -   -   -   1件:
97 
 71   Abi-m201   -   -   -   -   1件:
97 
 72   Abt-494   -   -   -   -   3件:
46,
96,
97 
 73   Abx464   Abx464   -   -   -   3件:
46,
96,
97 
 74   Abx464 100mg   Abx464   -   -   -   2件:
46,
97 
 75   Abx464 25mg   Abx464   -   -   -   1件:
97 
 76   Abx464 50mg   Abx464   -   -   -   2件:
46,
97 
 77   Accelerated 1 hour-infusion   -   -   -   -   2件:
96,
97 
 78   Accelerated 30 minutes-infusion   -   -   -   -   2件:
96,
97 
 79   Acetate   Acetate   -   -   -   40件:
1,
2,
6,
10,
13,
35,
40,
46,
49,
51,
60,
64,
70,
71,
73,
75,
76,
78,
81,
83,
85,
86,
88,
90,
96,
97,
113,
145,
156,
162,
171,
206,
222,
224,
225,
235,
265,
288,
298,
299 
 80   Acetic acid   Acetic acid   D00010   -   -   1件:
97 
 81   Active group   -   -   -   -   1件:
97 
 82   Adalimumab   Adalimumab   D02597   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   15件:
19,
37,
41,
46,
56,
84,
96,
97,
151,
160,
164,
222,
226,
269,
271 
 83   Adipose tissue-derived mesenchymal stem cells   -   -   -   -   1件:
97 
 84   Adipose-cord mesenchymal stromal cells (a-mscs)   -   -   -   -   1件:
97 
 85   Aeb071   -   -   -   -   1件:
97 
 86   Ag011   -   -   -   -   1件:
97 
 87   Ag011 - capsules   -   -   -   -   1件:
97 
 88   Ag011 - enema   -   -   -   -   1件:
97 
 89   Ajg501   -   -   -   -   1件:
97 
 90   Ajg511   -   -   -   -   1件:
97 
 91   Ajm300   -   -   -   -   1件:
97 
 92   Aldesleukin   Aldesleukin   D00748   3件: IL2RA, IL2RB, IL2RG   14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease (IBD), JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor   3件:
49,
65,
97 
 93   Alicaforsen   Alicaforsen   -   -   -   2件:
96,
97 
 94   Alkaline phosphatase   Alkaline phosphatase   -   -   -   3件:
46,
97,
172 
 95   Allopurinol   Allopurinol   D00224   1件: XDH   5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism   6件:
6,
46,
57,
66,
96,
97 
 96   Aloasc   -   -   -   -   1件:
97 
 97   Aloe   Aloe vera leaf   -   -   -   1件:
97 
 98   Aloe barbadensis miller   Aloe vera leaf   -   -   -   1件:
97 
 99   Alth12-1:4   -   -   -   -   1件:
97 
 100   Alth12-2:4   -   -   -   -   1件:
97 
 101   Amg 181   -   -   -   -   2件:
96,
97 
 102   Amgevita 40mg solution for injection   -   -   -   -   2件:
96,
97 
 103   Aminosalicylic acid   Aminosalicylic acid   D00162   -   -   2件:
96,
97 
 104   Amoxicillin   Amoxicillin   D00229, D02925, D07452   -   -   6件:
6,
46,
63,
96,
97,
222 
 105   Amoxicillin and tetracycline   Tetracycline   D00201   -   -   1件:
97 
 106   Amoxicillin, metronidazole and tetracycline   Metronidazole   D00409, D05016, D05017   -   -   1件:
97 
 107   And (andrographolide)   Andrographolide   -   -   -   1件:
97 
 108   Andosan   -   -   -   -   2件:
96,
97 
 109   Andrographis paniculata   -   -   -   -   1件:
97 
 110   Andrographis paniculata (ethanol extract)   Ethanol   D00068, D02798, D04855, D06542   -   -   1件:
97 
 111   Andrographolide   Andrographolide   -   -   -   1件:
97 
 112   Anrukinzumab   Anrukinzumab   D08857   1件: IL13   8件: Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease (IBD), JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation   1件:
97 
 113   Anti cd3   Muromonab   D05092   3件: CD3D, CD3E, CD3G   11件: Chagas disease (American trypanosomiasis), Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   1件:
97 
 114   Anti cd3 monoclonal antibody   Muromonab   D05092   3件: CD3D, CD3E, CD3G   11件: Chagas disease (American trypanosomiasis), Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   1件:
97 
 115   Anti tnf therapy including infliximab   Infliximab   D02598   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   2件:
96,
97 
 116   Anti-cd3   Muromonab   D05092   3件: CD3D, CD3E, CD3G   11件: Chagas disease (American trypanosomiasis), Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   2件:
96,
97 
 117   Anti-cd3 monoclonal antibody   Muromonab   D05092   3件: CD3D, CD3E, CD3G   11件: Chagas disease (American trypanosomiasis), Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   2件:
96,
97 
 118   Anti-ip-10 antibody   -   -   -   -   1件:
97 
 119   Anti-madcam antibody   -   -   -   -   2件:
96,
97 
 120   Anti-tnf discontinuation: physiological saline solution   -   -   -   -   2件:
96,
97 
 121   Anti-tnf drug   -   -   -   -   2件:
96,
97 
 122   Anti-tnf therapy   -   -   -   -   3件:
46,
96,
97 
 123   Anti-tnf: infliximab (infusion)   Infliximab   D02598   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   2件:
96,
97 
 124   Anti-tnf:adalimumab (subcutaneus)   Adalimumab   D02597   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   2件:
96,
97 
 125   Antibiotic cocktail   -   -   -   -   1件:
97 
 126   Aodg (apigenin-7-o-glucuronide)   Apigenin   -   -   -   1件:
97 
 127   Apd334   -   -   -   -   4件:
93,
96,
97,
269 
 128   Apigenin   Apigenin   -   -   -   1件:
97 
 129   Apixaban   Apixaban   D03213   1件: F10   1件: Complement and coagulation cascades   2件:
96,
97 
 130   Apixaban 2.5 milligram   Apixaban   D03213   1件: F10   1件: Complement and coagulation cascades   2件:
96,
97 
 131   Apremilast   Apremilast   D08860   4件: PDE4A, PDE4B, PDE4C, PDE4D   5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway   5件:
46,
50,
56,
97,
271 
 132   Apriso 0.375g er cap   -   -   -   -   1件:
97 
 133   Apriso 375 mg extended-release capsules   -   -   -   -   1件:
97 
 134   Apvo210   -   -   -   -   1件:
97 
 135   Aquamin®   -   -   -   -   1件:
97 
 136   Asacol   Mesalazine   D00377   -   -   1件:
97 
 137   Asacol (mesalamine)   Mesalazine   D00377   -   -   1件:
97 
 138   Asacol (mesalamine) delayed-release tablets   Mesalazine   D00377   -   -   1件:
97 
 139   Asacol 400 mg   -   -   -   -   1件:
97 
 140   Asacol 400 mg (mesalamine)   Mesalazine   D00377   -   -   1件:
97 
 141   Asacol 400 mg tablet   Mesalazine   D00377   -   -   1件:
97 
 142   Asacol 800 mg (mesalamine)   Mesalazine, Mesalazine   D00377   -   -   1件:
97 
 143   Asacol 800 mg tablet   Mesalazine   D00377   -   -   1件:
97 
 144   Asacol delayed release tablets   Mesalazine   D00377   -   -   1件:
97 
 145   Asacol delayed-release tablets   Mesalazine   D00377   -   -   1件:
97 
 146   Asacol tablet   Mesalazine   D00377   -   -   1件:
97 
 147   Asacol®   -   -   -   -   1件:
97 
 148   Asacol® 400 mg   -   -   -   -   1件:
97 
 149   Ascorbic acid   Ascorbic acid   D00018   -   -   2件:
10,
97 
 150   Asp3291   -   -   -   -   1件:
97 
 151   Aspergillus oryzae   Aspergillus oryzae   -   -   -   1件:
97 
 152   Ast-120   -   -   -   -   2件:
96,
97 
 153   Atl-2502   -   -   -   -   1件:
97 
 154   Avonex   Interferon beta-1a   D04554   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   2件:
13,
97 
 155   Avx 470   -   -   -   -   1件:
97 
 156   Azafor 50mg   -   -   -   -   1件:
97 
 157   Azathioprine   Azathioprine   D00238, D03033   -   -   18件:
11,
13,
19,
35,
42,
43,
44,
45,
46,
49,
65,
66,
85,
94,
95,
96,
97,
162 
 158   Azathioprine (aza)   Azathioprine   D00238, D03033   -   -   2件:
19,
97 
 159   Azathioprine (aza) or 6-mercaptopurine (6-mp)   Mercaptopurine   D00161, D04931   1件: HPRT1   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   2件:
96,
97 
 160   Azathioprine and allopurinol   Azathioprine   D00238, D03033   -   -   1件:
97 
 161   Azathioprine or 6-mercaptopurine   Mercaptopurine   D00161, D04931   1件: HPRT1   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   2件:
96,
97 
 162   Azatioprina   Azathioprine   D00238, D03033   -   -   3件:
13,
96,
97 
 163   B: 2 dosis   -   -   -   -   1件:
97 
 164   Bacteriotherapy   -   -   -   -   2件:
96,
97 
 165   Balsalazide   Balsalazide   D02715, D07488   -   -   1件:
97 
 166   Balsalazide disodium   Balsalazide   D02715, D07488   -   -   1件:
97 
 167   Baminercept   Baminercept   D08866   1件: LTB   3件: Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis   4件:
13,
46,
53,
97 
 168   Bascial prescription plus or minus herbs depend on symptoms   -   -   -   -   1件:
97 
 169   Basiliximab   Basiliximab   D03058   1件: IL2RA   11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor   6件:
2,
50,
65,
97,
222,
228 
 170   Bbt-401-1s, multiple doses   -   -   -   -   1件:
97 
 171   Bbt-401-1s, single dose   -   -   -   -   1件:
97 
 172   Beclometasone dipropionate   Beclomethasone dipropionate   D00689, D07495   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 173   Beclomethasone dipropionate   Beclomethasone dipropionate   D00689, D07495   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   2件:
97,
98 
 174   Beclomethasone diproprionate   -   -   -   -   1件:
97 
 175   Berberine   Berberine   D00092   -   -   1件:
97 
 176   Berberine chloride   Berberine   D00092   -   -   1件:
97 
 177   Bertilimumab   -   -   -   -   2件:
97,
162 
 178   Beta-1,3/1,6-d-glucan   -   -   -   -   1件:
97 
 179   Bg9418 (interferon beta-1a)   Human interferon beta   -   -   -   2件:
13,
97 
 180   Bg9924   -   -   -   -   2件:
46,
97 
 181   Bi 655130   -   -   -   -   3件:
37,
96,
97 
 182   Biap   -   -   -   -   2件:
46,
97 
 183   Bifidobacterium infantis   Bifidobacterium longum infantis   -   -   -   2件:
96,
97 
 184   Bifidobacterium infantis 35624   Bifidobacterium longum infantis   -   -   -   2件:
96,
97 
 185   Bimekizumab   Bimekizumab   D11550   2件: IL17A, IL17F   5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease (IBD), Rheumatoid arthritis, Th17 cell differentiation   3件:
46,
97,
271 
 186   Bio-enhanced curcumin soft gelatin capsule   Curcumin   -   -   -   1件:
97 
 187   Biologically active human fecal microbiota   -   -   -   -   1件:
97 
 188   Biopsies   -   -   -   -   1件:
97 
 189   Biosimilar   -   -   -   -   4件:
46,
96,
97,
271 
 190   Biosimilar infliximab   Infliximab   D02598   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   3件:
46,
96,
97 
 191   Bitter candytuft fresh plant extract   -   -   -   -   1件:
97 
 192   Bitterschleifenblume-ganzpflanze 1,5ml/10ml   -   -   -   -   1件:
97 
 193   Bl-7040   -   -   -   -   1件:
97 
 194   Blood sample   -   -   -   -   12件:
8,
13,
46,
49,
51,
53,
61,
66,
97,
274,
288,
299 
 195   Blood samples   -   -   -   -   8件:
13,
41,
46,
51,
61,
97,
227,
271 
 196   Bms-188667   Abatacept   D03203   2件: CD80, CD86   12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis   6件:
46,
49,
65,
96,
97,
271 
 197   Bms-986165   -   -   -   -   3件:
49,
96,
97 
 198   Bms-986166   -   -   -   -   1件:
97 
 199   Bms-986184   -   -   -   -   1件:
97 
 200   Boulardii   -   -   -   -   2件:
96,
97 
 201   Bovine intestinal alkaline phosphatase (biap)   Alkaline phosphatase   -   -   -   1件:
97 
 202   Bovine-calf alkaline phosphatase (biap)   Alkaline phosphatase   -   -   -   1件:
97 
 203   Bovine-calf alkaline phosphatase biap   Alkaline phosphatase   -   -   -   1件:
97 
 204   Brazikumab   -   -   -   -   2件:
96,
97 
 205   Bt-11 (1000 mg)   -   -   -   -   1件:
97 
 206   Bt-11 (500 mg)   -   -   -   -   1件:
97 
 207   Bt-11 active   -   -   -   -   2件:
96,
97 
 208   Budenofalk 2mg rectal foam   -   -   -   -   1件:
97 
 209   Budenofalk 3mg   -   -   -   -   2件:
93,
97 
 210   Budenofalk rectal foam   -   -   -   -   1件:
97 
 211   Budesonide   Budesonide   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   9件:
66,
93,
94,
95,
96,
97,
98,
228,
299 
 212   Budesonide (6 mg)   Budesonide   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 213   Budesonide (9 mg)   Budesonide   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 214   Budesonide 6 mg capsules, hard (bux-pvii prototype)   Budesonide   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 215   Budesonide 9 mg capsules, hard (bux-pv)   Budesonide   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 216   Budesonide 9 mg capsules, hard (bux-pvii prototype)   Budesonide   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 217   Budesonide mmx 6 mg tablet   Budesonide   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 218   Budesonide mmx®   Budesonide   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 219   Budesonide mmx® 6 mg   Budesonide   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 220   Budesonide mmx® 9 mg   Budesonide   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 221   Budesonide-mmx   Budesonide   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 222   Budesonide-mmx®   Budesonide   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 223   Budesonide-mmx® 6 mg   Budesonide   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 224   Budesonide-mmx® 9 mg   Budesonide   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 225   Budesonide-mmx™   Budesonide   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 226   Butanoic acid   Butyric acid   D05866   -   -   3件:
34,
51,
97 
 227   Caffeine   Caffeine   D00528, D01453   11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A   22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   6件:
2,
6,
46,
78,
96,
97 
 228   Calcitonin nasal spray (salmon)   -   -   -   -   2件:
96,
97 
 229   Calcium   Calcium   -   -   -   24件:
6,
13,
19,
46,
49,
51,
65,
68,
75,
79,
84,
93,
94,
95,
96,
97,
214,
215,
222,
224,
235,
265,
298,
299 
 230   Cannabidiol   Cannabidiol   D10915   2件: CNR1, CNR2   4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis   13件:
6,
13,
46,
95,
96,
97,
140,
144,
145,
157,
158,
193,
271 
 231   Cannabis   Medical cannabis   -   -   -   6件:
2,
6,
13,
90,
96,
97 
 232   Cannabis, medical   Medical cannabis   -   -   -   5件:
2,
6,
13,
96,
97 
 233   Carbon   Activated charcoal   D03251   -   -   7件:
6,
46,
85,
86,
96,
97,
298 
 234   Carbon dioxide   Carbon dioxide   D00004   -   -   1件:
97 
 235   Carnitine   Levocarnitine   D02030, D02176, D04713   -   -   8件:
5,
13,
58,
96,
97,
265,
298,
316 
 236   Carrageenan   -   -   -   -   1件:
97 
 237   Carvi extractum fluidum   -   -   -   -   1件:
97 
 238   Casein   Casein   -   -   -   1件:
97 
 239   Casein glycomacropeptide (cgmp)   Casein   -   -   -   1件:
97 
 240   Cat-354   -   -   -   -   1件:
97 
 241   Catridecacog   Catridecacog   D10532   -   -   2件:
97,
288 
 242   Cb-01-02   -   -   -   -   1件:
97 
 243   Cb-01-05-mmx   -   -   -   -   1件:
97 
 244   Ceftriaxone   Ceftriaxone   D00924, D07659   -   -   3件:
2,
6,
97 
 245   Cefuroxime   Cefuroxime   D00262, D00914, D00915, D03431   -   -   1件:
97 
 246   Certolizumab pegol   Certolizumab pegol   D03441   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   6件:
37,
46,
96,
97,
226,
271 
 247   Cgmp   Cyclic gmp   -   -   -   1件:
97 
 248   Cgmp protein   Cyclic gmp   -   -   -   1件:
97 
 249   Chloride   Chloride ion   -   -   -   17件:
6,
11,
13,
14,
34,
46,
51,
96,
97,
127,
168,
193,
227,
228,
288,
297,
299 
 250   Chlorogenic acid   Chlorogenic acid   -   -   -   1件:
97 
 251   Cholecalciferol   Cholecalciferol   D00188   1件: VDR   4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   9件:
13,
19,
34,
46,
49,
96,
97,
298,
299 
 252   Ciclosporin   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   13件:
26,
46,
49,
50,
53,
55,
60,
61,
97,
222,
226,
228,
269 
 253   Cimzia   Certolizumab pegol   D03441   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   4件:
46,
96,
97,
271 
 254   Ciprofloxacin   Ciprofloxacin   D00186, D02216   -   -   5件:
2,
60,
96,
97,
299 
 255   Cla (chlorogenic acid)   Chlorogenic acid   -   -   -   1件:
97 
 256   Clarithromycin   Clarithromycin   D00276   -   -   8件:
6,
63,
84,
96,
97,
222,
228,
299 
 257   Clipper   -   -   -   -   1件:
97 
 258   Clotrimazole   Clotrimazole   D00282   -   -   1件:
97 
 259   Cnto148   -   -   -   -   2件:
46,
97 
 260   Coamoxiclav   -   -   -   -   1件:
97 
 261   Cobitolimod   Cobitolimod   -   -   -   1件:
97 
 262   Coffee coal   -   -   -   -   1件:
97 
 263   Colal-pred   -   -   -   -   1件:
97 
 264   Colal-pred®   -   -   -   -   1件:
97 
 265   Coltect   -   -   -   -   1件:
97 
 266   Combination oral budesonide and rectal hydrocortisone   Hydrocortisone   D00088   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 267   Corticosteroid   -   -   -   -   10件:
13,
42,
43,
44,
45,
66,
84,
96,
97,
222 
 268   Corticosteroids   -   -   -   -   9件:
41,
46,
49,
64,
97,
164,
220,
296,
300 
 269   Corticosteroids only   -   -   -   -   1件:
97 
 270   Corticosteroids then mesalamine   Mesalazine   D00377   -   -   1件:
97 
 271   Cortimentmmx 9 mg   -   -   -   -   1件:
97 
 272   Cosmofer   -   -   -   -   2件:
96,
97 
 273   Cosmofer 50mg/ml solution for infusion or injection   -   -   -   -   2件:
96,
97 
 274   Cotrimoxazole   -   -   -   -   2件:
85,
97 
 275   Cp- 690 550   -   -   -   -   1件:
97 
 276   Cp-690,500 5 mg   -   -   -   -   1件:
97 
 277   Cp-690,550   -   -   -   -   4件:
46,
96,
97,
271 
 278   Cp-690,550 10 mg   -   -   -   -   1件:
97 
 279   Cp-690,550-10   -   -   -   -   3件:
46,
96,
97 
 280   Cp690,550   -   -   -   -   2件:
46,
97 
 281   Cs (corticosteroids) only   -   -   -   -   1件:
97 
 282   Ct-p13   -   -   -   -   4件:
46,
96,
97,
271 
 283   Curcumin   Curcumin   -   -   -   10件:
13,
46,
49,
67,
74,
94,
96,
97,
139,
299 
 284   Cyclosporin   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   16件:
14,
38,
39,
49,
53,
56,
60,
62,
63,
97,
113,
164,
222,
223,
274,
326 
 285   Cyclosporine   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   33件:
11,
14,
19,
20,
28,
36,
40,
41,
42,
45,
46,
49,
50,
53,
56,
58,
60,
62,
64,
65,
90,
95,
97,
162,
164,
222,
226,
228,
234,
283,
284,
285,
302 
 286   Cyclosporine (usan)   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   1件:
97 
 287   Cyclosporine vs infliximab   Infliximab   D02598   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   1件:
97 
 288   Cycol   -   -   -   -   1件:
97 
 289   Cycol™   -   -   -   -   1件:
97 
 290   D-proline   Proline   D00035   -   -   1件:
97 
 291   Daclizumab   Daclizumab   D03639   1件: IL2RA   11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor   7件:
13,
56,
60,
65,
97,
283,
284 
 292   Dacortin   Prednisone   D00473   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   2件:
46,
97 
 293   Dand (14-deoxyandrographolide)   -   -   -   -   1件:
97 
 294   Ddand (14-deoxy-11,12-didehydroandrographolide)   -   -   -   -   1件:
97 
 295   Decortin   Prednisone   D00473   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   5件:
46,
96,
97,
113,
145 
 296   Decortin h 1 mg   Prednisone   D00473   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 297   Decortin h 10mg   Prednisone   D00473   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 298   Decortin h 20mg   Prednisone   D00473   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 299   Decortin h 50 mg   Prednisone   D00473   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 300   Decortin h 5mg   Prednisone   D00473   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 301   Dekristol   -   -   -   -   2件:
13,
97 
 302   Deligoparin   -   -   -   -   1件:
97 
 303   Delmitide acetate   Acetate   -   -   -   1件:
97 
 304   Deltacortene   -   -   -   -   1件:
97 
 305   Dersalazine   Dersalazine   -   -   -   1件:
97 
 306   Dersalazine sodium   Dersalazine   -   -   -   1件:
97 
 307   Dexamethasone   Dexamethasone   D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   20件:
13,
16,
28,
35,
46,
53,
63,
65,
70,
74,
75,
81,
83,
84,
90,
96,
97,
222,
296,
299 
 308   Dexamethasone 21-phosphate   Dexamethasone   D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 309   Dextran   Dextran   D00060   -   -   5件:
2,
62,
79,
96,
97 
 310   Dextromethorphan   Dextromethorphan   D00848, D03742, D03744   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   9件:
2,
6,
8,
13,
46,
78,
96,
97,
156 
 311   Dims0150   -   -   -   -   1件:
97 
 312   Doxycycline   Doxycycline   D00307, D02129, D03903, D03904, D07876   -   -   15件:
13,
23,
28,
46,
84,
85,
89,
96,
97,
158,
162,
167,
227,
280,
299 
 313   E. coli nissle   -   -   -   -   1件:
97 
 314   Ecologic 825   -   -   -   -   1件:
97 
 315   Egf enema   -   -   -   -   1件:
97 
 316   Eicosapentaenoic acid   Icosapent   D08061   -   -   5件:
49,
96,
97,
296,
297 
 317   Emea/h/c/000481   -   -   -   -   1件:
97 
 318   Encapsulated faecal microbiota   -   -   -   -   1件:
97 
 319   Encapsulated faecal microbiota filtrate   -   -   -   -   1件:
97 
 320   Entecavir   Entecavir   D04008, D07896   -   -   5件:
46,
56,
96,
97,
271 
 321   Entocort ec® 3 mg   Budesonide   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 322   Entocort® cr   -   -   -   -   1件:
97 
 323   Entyvio   Vedolizumab   D08083   2件: ITGA4, ITGB7   15件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection   2件:
96,
97 
 324   Entyvio 300mg   Vedolizumab   D08083   2件: ITGA4, ITGB7   15件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection   1件:
97 
 325   Epaxal berna (virosomal hepatitis a vaccine)   Hepatitis a vaccine   -   -   -   2件:
96,
97 
 326   Epidermal growth factor   -   -   -   -   1件:
97 
 327   Epidermal growth factor enema   -   -   -   -   1件:
97 
 328   Ergocalciferol   Ergocalciferol   D00187   1件: VDR   4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   5件:
46,
84,
96,
97,
299 
 329   Ethanol   Ethanol   D00068, D02798, D04855, D06542   -   -   3件:
97,
279,
280 
 330   Etrasimod   Etrasimod   D10930   5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5   3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   1件:
97 
 331   Etrolizumab   Etrolizumab   D09901   1件: ITGB7   11件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer   2件:
96,
97 
 332   Etrozulimab   -   -   -   -   1件:
97 
 333   Eubacterial spores, purified suspension, encapsulated   -   -   -   -   1件:
97 
 334   Exposure to golimumab   Golimumab   D04358   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   1件:
97 
 335   Faecal microbiota transplantation   -   -   -   -   2件:
96,
97 
 336   Fe 999301   -   -   -   -   2件:
96,
97 
 337   Fecal microbial transplant   -   -   -   -   2件:
96,
97 
 338   Fecal microbial transplantation   -   -   -   -   2件:
96,
97 
 339   Fecal microbiota   -   -   -   -   2件:
13,
97 
 340   Fecal microbiota enema   -   -   -   -   1件:
97 
 341   Fecal microbiota transplant   -   -   -   -   2件:
96,
97 
 342   Fecal microbiota transplantation   -   -   -   -   5件:
2,
66,
94,
96,
97 
 343   Fecal microbiota transplantation (fmt)   -   -   -   -   2件:
96,
97 
 344   Fecal microbiota transplantation (fmt), openbiome   -   -   -   -   1件:
97 
 345   Ferric carboxymaltose   Ferric carboxymaltose   D08920   -   -   4件:
86,
96,
97,
299 
 346   Ferrous sulphate   -   -   -   -   2件:
96,
97 
 347   Filgotinib   Filgotinib   D10871   1件: JAK1   26件: EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis   6件:
46,
53,
96,
97,
222,
271 
 348   Fitc-adalimumab   Adalimumab   D02597   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   2件:
96,
97 
 349   Flagyl   Metronidazole   D00409, D05016, D05017   -   -   2件:
96,
97 
 350   Flaxseed lignan-enriched complex (flc)   -   -   -   -   1件:
97 
 351   Flixabi   Infliximab   D02598   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   1件:
97 
 352   Fluorescein   Fluorescein   D01261, D02024   -   -   2件:
19,
97 
 353   Flupentixol   Flupentixol   D01044   2件: DRD1, DRD2   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
97 
 354   Fmt infusions   -   -   -   -   1件:
97 
 355   Fosfomycin   Fosfomycin   D00925, D02187, D02188, D04253   -   -   2件:
96,
97 
 356   Fp-110   -   -   -   -   1件:
97 
 357   Fp-cya-050   -   -   -   -   1件:
97 
 358   Fp-cya-053   -   -   -   -   1件:
97 
 359   Freeze-dried black raspberry powder   Raspberry   -   -   -   1件:
97 
 360   G321605   -   -   -   -   3件:
85,
96,
97 
 361   Ganciclovir   Ganciclovir   D00333, D04301   -   -   3件:
28,
60,
97 
 362   Gastro-resistant phosphatidylcholine granules   -   -   -   -   1件:
97 
 363   Gb004   -   -   -   -   1件:
97 
 364   Ged-0301   -   -   -   -   2件:
96,
97 
 365   Ged-0507-34-levo   -   -   -   -   1件:
97 
 366   Ged-0507-34-levo 160 mg   -   -   -   -   1件:
97 
 367   Ged-0507-34-levo 80 mg   -   -   -   -   1件:
97 
 368   Ged0507   -   -   -   -   1件:
97 
 369   Gelatin   Gelatin   D00115, D06892   -   -   4件:
47,
78,
97,
269 
 370   Gi-270384   -   -   -   -   1件:
97 
 371   Glpg0974   Glpg0974   -   -   -   1件:
97 
 372   Glpg1205   Glpg1205   -   -   -   3件:
85,
96,
97 
 373   Glutamine   L-glutamine   D00015   -   -   6件:
87,
96,
97,
113,
245,
299 
 374   Glycyrrhiza   Glycyrrhiza glabra   -   -   -   1件:
97 
 375   Glycyrrhiza glabra   Glycyrrhiza glabra   -   -   -   1件:
97 
 376   Glycyrrhiza glabra root   Glycyrrhiza glabra   -   -   -   1件:
97 
 377   Golimumab   Golimumab   D04358   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   5件:
46,
84,
96,
97,
271 
 378   Golimumab (glm)   Golimumab   D04358   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   1件:
97 
 379   Golimumab (optimization)   Golimumab   D04358   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   1件:
97 
 380   Golimumab 1 mg per kg   Golimumab   D04358   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   1件:
97 
 381   Golimumab 100 mg   Golimumab   D04358   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   2件:
46,
97 
 382   Golimumab 2 mg per kg   Golimumab   D04358   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   1件:
97 
 383   Golimumab 200 mg   Golimumab   D04358   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   1件:
97 
 384   Golimumab 4 mg per kg   Golimumab   D04358   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   1件:
97 
 385   Golimumab 400 mg   Golimumab   D04358   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   1件:
97 
 386   Golimumab 50 mg   Golimumab   D04358   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   2件:
46,
97 
 387   Golimumab 50 mg in patients <80 kg and golimumab 100 mg in patients >80 kg   Golimumab   D04358   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   1件:
97 
 388   Golimumab dose 1   Golimumab   D04358   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   1件:
97 
 389   Golimumab dose 2   Golimumab   D04358   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   1件:
97 
 390   Golimumab prefilled syringe   Golimumab   D04358   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   1件:
97 
 391   Golimumab treatment optimization.   Golimumab   D04358   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   1件:
97 
 392   Gralise   Gabapentin   D00332   5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1   9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cardiac muscle contraction, Dilated cardiomyopathy (DCM), GABAergic synapse, Hypertrophic cardiomyopathy (HCM), MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle   2件:
97,
226 
 393   Granulated mesalamine   Mesalazine   D00377   -   -   1件:
97 
 394   Grapefruit   Grapefruit   -   -   -   5件:
6,
46,
50,
83,
97 
 395   Group 1- control diet   -   -   -   -   1件:
97 
 396   Group 2- ucd diet   -   -   -   -   1件:
97 
 397   Gs-4875   -   -   -   -   1件:
97 
 398   Gs-5745   -   -   -   -   2件:
46,
97 
 399   Gs-5745 iv   -   -   -   -   1件:
97 
 400   Gs-5745 sc   -   -   -   -   1件:
97 
 401   Gs-6034   -   -   -   -   3件:
46,
96,
97 
 402   Gsk1399686   -   -   -   -   1件:
97 
 403   Gsk1605786   -   -   -   -   2件:
96,
97 
 404   Gsk1605786a   -   -   -   -   2件:
96,
97 
 405   Gsk2586184 400mg   -   -   -   -   1件:
97 
 406   Gsk2831781   -   -   -   -   1件:
97 
 407   Gsk2982772   -   -   -   -   2件:
46,
97 
 408   Gsk2982772a, where a denotes the free base   -   -   -   -   2件:
46,
97 
 409   Guaiazulene   Guaiazulen   -   -   -   1件:
97 
 410   Guselkumab   Guselkumab   D10438   1件: IL23A   9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis   3件:
37,
96,
97 
 411   Guselkumab dose 1   Guselkumab   D10438   1件: IL23A   9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis   1件:
97 
 412   Guselkumab dose 2   Guselkumab   D10438   1件: IL23A   9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis   1件:
97 
 413   Gwp42003   -   -   -   -   1件:
97 
 414   He3286   He3286   -   -   -   2件:
46,
97 
 415   Hemay007   -   -   -   -   1件:
97 
 416   Hepatitis a vaccine   Hepatitis a vaccine   -   -   -   3件:
46,
96,
97 
 417   Herbal treatment (sa100)   -   -   -   -   1件:
97 
 418   Hextend   Hydroxyethyl starch   D03335   -   -   2件:
96,
97 
 419   Hgd40   -   -   -   -   1件:
97 
 420   Hgs1025   -   -   -   -   1件:
97 
 421   High dose   -   -   -   -   1件:
97 
 422   Hmpl-004   -   -   -   -   1件:
97 
 423   Hmpl-004 tablet   -   -   -   -   1件:
97 
 424   Hmpl004-6599   -   -   -   -   2件:
96,
97 
 425   Hum291   -   -   -   -   2件:
96,
97 
 426   Human anti-tnf-alpha monoclonal antibody   -   -   -   -   2件:
46,
97 
 427   Humira   Adalimumab   D02597   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   6件:
46,
84,
96,
97,
269,
271 
 428   Humira 40 mg solution for injection in pre-filled syringe   Adalimumab   D02597   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   3件:
46,
96,
97 
 429   Humira 40 mg solution for injection in pre-filled syringes   Adalimumab   D02597   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   1件:
97 
 430   Humira 40 mg/0.8 ml solution for injection for paediatric use   Adalimumab   D02597   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   1件:
97 
 431   Humira 40mg solution for injection   -   -   -   -   2件:
96,
97 
 432   Humira®   Adalimumab   D02597   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   4件:
46,
96,
97,
271 
 433   Hyaluronate   Hyaluronic acid   D08043   -   -   2件:
53,
97 
 434   Hydrocortisone   Hydrocortisone   D00088   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   8件:
6,
53,
75,
78,
81,
83,
97,
299 
 435   Hydrocortisone sodium succinate   Hydrocortisone   D00088   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 436   Hydrogen   Hydrogen   -   -   -   5件:
5,
6,
17,
97,
226 
 437   Hydroxide   Hydroxide ion   -   -   -   4件:
46,
96,
97,
284 
 438   Ibd98-m   -   -   -   -   1件:
97 
 439   Ibd98-m delayed-release capsules   -   -   -   -   1件:
97 
 440   Iberogast n   -   -   -   -   1件:
97 
 441   Im90838   -   -   -   -   1件:
97 
 442   Impact   Topramezone   -   -   -   7件:
6,
13,
46,
50,
96,
97,
299 
 443   Imu-838   -   -   -   -   1件:
97 
 444   Imuran   Azathioprine   D00238, D03033   -   -   2件:
96,
97 
 445   Imurek 25mg filmtabletten   -   -   -   -   1件:
97 
 446   Imurek 50mg filmtabletten   -   -   -   -   1件:
97 
 447   Imurel   -   -   -   -   2件:
96,
97 
 448   Inflectra   Infliximab   D02598   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   2件:
96,
97 
 449   Infliximab   Infliximab   D02598   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   22件:
35,
37,
38,
39,
40,
41,
43,
45,
46,
49,
50,
56,
65,
84,
95,
96,
97,
98,
162,
164,
269,
271 
 450   Infliximab (ifx)   Infliximab   D02598   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   1件:
97 
 451   Infliximab 10 mg/kg   Infliximab   D02598   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   3件:
46,
96,
97 
 452   Infliximab 5 mg/kg   Infliximab   D02598   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   2件:
96,
97 
 453   Infliximab [infliximab biosimilar 3]   Infliximab   D02598   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   4件:
37,
46,
96,
97 
 454   Infliximab and adalimumab   Adalimumab, Infliximab   D02597, D02598   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   2件:
96,
97 
 455   Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab   Ustekinumab, Vedolizumab   D08083, D09214   5件: IL12A, IL12B, IL23A, ITGA4, ITGB7   39件: African trypanosomiasis, Allograft rejection, Amoebiasis, Arrhythmogenic right ventricular cardiomyopathy (ARVC), C-type lectin receptor signaling pathway, Cell adhesion molecules (CAMs), Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Inflammatory bowel disease (IBD), Influenza A, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, Malaria, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Yersinia infection   2件:
96,
97 
 456   Infliximab, adalimumab, certolizumab pegol   Certolizumab pegol   D03441   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   2件:
96,
97 
 457   Innovator infliximab   Infliximab   D02598   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   3件:
46,
96,
97 
 458   Inositol   Inositol   D08079   -   -   2件:
96,
97 
 459   Interferon beta   Human interferon beta   -   -   -   6件:
13,
14,
20,
26,
96,
97 
 460   Interferon beta-1a   Human interferon beta   -   -   -   5件:
13,
14,
26,
96,
97 
 461   Interferon-beta   Human interferon beta   -   -   -   2件:
13,
97 
 462   Interferon-beta-1a   Interferon beta-1a   D04554   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   2件:
13,
97 
 463   Interferon-beta-1a, 44 microgram   Interferon beta-1a   D04554   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
97 
 464   Interferon-beta-1a, 66 microgram   Interferon beta-1a   D04554   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
97 
 465   Interleukin 2   Human interleukin-2   -   -   -   9件:
46,
49,
51,
56,
63,
95,
96,
97,
271 
 466   Interleukin-2   Human interleukin-2   -   -   -   6件:
2,
35,
49,
55,
65,
97 
 467   Interleukin-2 (aldesleukin).   Aldesleukin   D00748   3件: IL2RA, IL2RB, IL2RG   14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease (IBD), JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor   1件:
97 
 468   Iron   Iron   -   -   -   7件:
13,
62,
86,
96,
97,
254,
284 
 469   Iron sucrose   Sucrose   D00025   -   -   3件:
62,
96,
97 
 470   Iron sulphate   Iron   -   -   -   2件:
96,
97 
 471   Iron sulphate 200mg coated tablets   Iron   -   -   -   2件:
96,
97 
 472   Iron supplement 300-600 mg/day   Iron   -   -   -   2件:
96,
97 
 473   Iron(iii)- hydroxide dextran complex   Dextran   D00060   -   -   2件:
96,
97 
 474   Itacitinib   Itacitinib   D10944   1件: JAK1   26件: EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis   4件:
46,
60,
97,
228 
 475   Jenapharm   Acetylcysteine   D00221   -   -   2件:
96,
97 
 476   Jnj-54781532 150 mg once daily   -   -   -   -   1件:
97 
 477   Jnj-54781532 25 mg once daily   -   -   -   -   1件:
97 
 478   Jnj-54781532 75 mg once daily   -   -   -   -   1件:
97 
 479   Jnj-54781532 75 mg twice daily   -   -   -   -   1件:
97 
 480   K(d)pt   -   -   -   -   1件:
97 
 481   Kamillenblüten 3ml/10ml   -   -   -   -   1件:
97 
 482   Kappaproct   -   -   -   -   1件:
97 
 483   Kdpt   -   -   -   -   1件:
97 
 484   Khk4083   -   -   -   -   1件:
97 
 485   Kremezin   -   -   -   -   2件:
96,
97 
 486   Kremezin®, spherical adsorptive carbon   Activated charcoal   D03251   -   -   2件:
96,
97 
 487   Krp203a   -   -   -   -   1件:
97 
 488   Kyo-dophilus   -   -   -   -   1件:
97 
 489   Kümmel 2ml/10ml   -   -   -   -   1件:
97 
 490   L-carnitine   Levocarnitine   D02030, D02176, D04713   -   -   6件:
13,
96,
97,
265,
298,
316 
 491   L-lysyl-d-prolyl-l-threonine acetate   Acetate   -   -   -   1件:
97 
 492   L-threonine   L-threonine   D00041   -   -   1件:
97 
 493   Lactated ringers   -   -   -   -   2件:
96,
97 
 494   Lactobacillus casei dg   -   -   -   -   1件:
97 
 495   Lactobacillus gg   -   -   -   -   1件:
97 
 496   Lactobacillus reuteri   Lactobacillus reuteri   -   -   -   2件:
97,
299 
 497   Lactobacillus rhamnosus gg atcc 53103   -   -   -   -   1件:
97 
 498   Lactobacillus salivarius ucc118   -   -   -   -   2件:
96,
97 
 499   Lactobacilus acidophilus & bifidobacterium animalis/lactis   -   -   -   -   1件:
97 
 500   Lactose   Lactose   D00046, D03226   -   -   6件:
2,
6,
13,
97,
228,
310 
 501   Lactose in water   Lactose   D00046, D03226   -   -   1件:
97 
 502   Lc51-0255   -   -   -   -   1件:
97 
 503   Levocarnitine   Levocarnitine   D02030, D02176, D04713   -   -   3件:
3,
53,
97 
 504   Levocarnitine propyl hydrochloride   Levocarnitine   D02030, D02176, D04713   -   -   1件:
97 
 505   Linaclotide   Linaclotide   D09355   1件: GUCY2C   2件: Metabolic pathways, Purine metabolism   1件:
97 
 506   Lixacol   -   -   -   -   1件:
97 
 507   Loperamide   Loperamide   D00729, D07113, D08144   3件: OPRD1, OPRK1, OPRM1   5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway   2件:
13,
97 
 508   Losartan   Losartan   D00357, D08146   1件: AGTR1   14件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   18件:
13,
17,
19,
46,
58,
66,
67,
85,
96,
97,
98,
113,
164,
167,
179,
215,
222,
299 
 509   Low dose   -   -   -   -   1件:
97 
 510   Low dose naltrexone   Naltrexone   D02095, D05113   3件: OPRD1, OPRK1, OPRM1   5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway   2件:
96,
97 
 511   Low fodmap   -   -   -   -   1件:
97 
 512   Lt-02   -   -   -   -   1件:
97 
 513   Lt-02 (modified-release pc pellets)   -   -   -   -   1件:
97 
 514   Lumbar puncture   -   -   -   -   3件:
13,
96,
97 
 515   Lx1606   -   -   -   -   1件:
97 
 516   Ly3074828   -   -   -   -   1件:
97 
 517   Lyc-30937   -   -   -   -   1件:
97 
 518   Lyc-30937-ec   -   -   -   -   1件:
97 
 519   Lys006   -   -   -   -   1件:
97 
 520   Lysine   L-lysine   D02304   -   -   4件:
13,
97,
228,
299 
 521   Lysine-d-proline-threonine   Proline   D00035   -   -   1件:
97 
 522   Magnesium   Magnesium   -   -   -   15件:
6,
11,
13,
46,
64,
93,
97,
166,
225,
235,
284,
291,
296,
297,
298 
 523   Magnesium citrate   Magnesium citrate   D03265   -   -   1件:
97 
 524   Maltodextrin   Maltodextrin   D02329   -   -   4件:
6,
13,
96,
97 
 525   Maltose   Maltose   D00044   -   -   2件:
96,
97 
 526   Mare´s milk   -   -   -   -   2件:
96,
97 
 527   Matricaria flower   Chamomile   D09212   -   -   1件:
97 
 528   Matricaria recutita l. flos   -   -   -   -   1件:
97 
 529   Maximal oral 5asa   Mesalazine   D00377   -   -   1件:
97 
 530   Md-0901   -   -   -   -   1件:
97 
 531   Mdx-1100   -   -   -   -   2件:
46,
97 
 532   Mdx-1100 (anti-cxcl10 human monoclonal antibody)   -   -   -   -   1件:
97 
 533   Medi7183 high dose   -   -   -   -   1件:
97 
 534   Medi7183 low dose   -   -   -   -   1件:
97 
 535   Medi7183 medium dose   -   -   -   -   1件:
97 
 536   Melatonin   Melatonin   D08170   2件: MTNR1A, MTNR1B   2件: Circadian entrainment, Neuroactive ligand-receptor interaction   8件:
6,
13,
46,
49,
90,
97,
144,
202 
 537   Melissae folii dry aqueous extract   -   -   -   -   1件:
97 
 538   Melissenblätter 15ml/10ml   -   -   -   -   1件:
97 
 539   Melitracen   Melitracen   D08171   -   -   1件:
97 
 540   Mentha × piperita l. folium   -   -   -   -   1件:
97 
 541   Mercaptopurine   Mercaptopurine   D00161, D04931   1件: HPRT1   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   3件:
96,
97,
164 
 542   Mercaptopurine (puri-nethol)   Mercaptopurine   D00161, D04931   1件: HPRT1   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   1件:
97 
 543   Mesalamin   -   -   -   -   1件:
97 
 544   Mesalamine   Mesalazine   D00377   -   -   3件:
96,
97,
164 
 545   Mesalamine delayed release tablets 400mg   Mesalazine   D00377   -   -   1件:
97 
 546   Mesalamine enema   Mesalazine   D00377   -   -   1件:
97 
 547   Mesalamine granules   Mesalazine   D00377   -   -   1件:
97 
 548   Mesalamine once-daily   Mesalazine   D00377   -   -   1件:
97 
 549   Mesalamine pellets   Mesalazine   D00377   -   -   1件:
97 
 550   Mesalamine twice-daily   Mesalazine   D00377   -   -   1件:
97 
 551   Mesalamine, 5-asa   Mesalazine   D00377   -   -   1件:
97 
 552   Mesalazine   Mesalazine   D00377   -   -   3件:
46,
96,
97 
 553   Mesalazine (3,600 mg)   Mesalazine   D00377   -   -   1件:
97 
 554   Mesalazine - tid 1000 mg   Mesalazine   D00377   -   -   1件:
97 
 555   Mesalazine - tid 2x 500 mg   Mesalazine   D00377   -   -   1件:
97 
 556   Mesalazine 1000 mg gastro-resistant tablets   Mesalazine   D00377   -   -   1件:
97 
 557   Mesalazine 250mg   Mesalazine   D00377   -   -   1件:
97 
 558   Mesalazine 250mg tablet and nitazoxanide 500mg oral tablet   Nitazoxanide   D02486   -   -   1件:
97 
 559   Mesalazine 4g enema   Mesalazine   D00377   -   -   1件:
97 
 560   Mesalazine 500 mg gastro-resistant tablets (salofalk® 500 mg)   Mesalazine   D00377   -   -   1件:
97 
 561   Mesalazine enema   Mesalazine   D00377   -   -   1件:
97 
 562   Mesalazine tablet   Mesalazine   D00377   -   -   1件:
97 
 563   Mesalazine with hydrocortisone sodium succinate   Hydrocortisone   D00088   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 564   Mesalazinum   Mesalazine   D00377   -   -   1件:
97 
 565   Mesenchymal cells   -   -   -   -   1件:
97 
 566   Mesenchymal stromal cells   -   -   -   -   6件:
36,
51,
96,
97,
274,
284 
 567   Met-2   -   -   -   -   1件:
97 
 568   Methotrexate   Methotrexate   D00142, D02115   2件: DHFR, DHFR2   4件: Antifolate resistance, Folate biosynthesis, Metabolic pathways, One carbon pool by folate   33件:
11,
13,
19,
34,
35,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
55,
56,
60,
62,
65,
84,
93,
96,
97,
162,
164,
172,
256,
271,
284,
285,
326,
331 
 569   Methotrexate bellon   Methotrexate   D00142, D02115   2件: DHFR, DHFR2   4件: Antifolate resistance, Folate biosynthesis, Metabolic pathways, One carbon pool by folate   1件:
97 
 570   Methotrexate bellon 25mg/ml   Methotrexate   D00142, D02115   2件: DHFR, DHFR2   4件: Antifolate resistance, Folate biosynthesis, Metabolic pathways, One carbon pool by folate   1件:
97 
 571   Methylene blue   Methylene blue   D02312, D10537   -   -   1件:
97 
 572   Methylene blue 25mg tablets   Methylene blue   D02312, D10537   -   -   1件:
97 
 573   Methylprednisolone   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   36件:
2,
13,
25,
26,
35,
38,
39,
40,
41,
42,
43,
45,
46,
49,
50,
51,
60,
63,
64,
65,
66,
83,
84,
86,
96,
97,
145,
164,
220,
222,
224,
271,
283,
284,
285,
296 
 574   Metronidazole   Metronidazole   D00409, D05016, D05017   -   -   8件:
46,
51,
63,
94,
95,
96,
97,
291 
 575   Metronidazole capsule 50 mg   Metronidazole   D00409, D05016, D05017   -   -   1件:
97 
 576   Mezavant   Mesalazine   D00377   -   -   1件:
97 
 577   Mezavant 1200 mg magensaftresistente retardtabletten   Mesalazine   D00377   -   -   1件:
97 
 578   Mezavant xl   Mesalazine   D00377   -   -   1件:
97 
 579   Mezavant xl 1200 mg gastro-resistant, prolonged release tablets   Mesalazine   D00377   -   -   1件:
97 
 580   Mezavant xl 1200 mg gastro-resistant, prolonged release tablets.   Mesalazine   D00377   -   -   1件:
97 
 581   Mezavant xl gastro-resistant, prolonged release tablets   Mesalazine   D00377   -   -   1件:
97 
 582   Midazolam   Midazolam   D00550, D00696, D05028   16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   10件:
2,
3,
6,
13,
46,
70,
96,
97,
231,
298 
 583   Mirikizumab   Mirikizumab   D11123   1件: IL23A   9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis   2件:
96,
97 
 584   Mk-8259   -   -   -   -   1件:
97 
 585   Mln0002   -   -   -   -   2件:
96,
97 
 586   Mln0002 (vedolizumab)   Vedolizumab   D08083   2件: ITGA4, ITGB7   15件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection   2件:
96,
97 
 587   Mln002   -   -   -   -   2件:
96,
97 
 588   Mmx mesalamine   Mesalazine   D00377   -   -   1件:
97 
 589   Mmx mesalamine/mesalazine   Mesalazine   D00377   -   -   1件:
97 
 590   Mmx mesalamine/mesalazine (high dose)   Mesalazine   D00377   -   -   1件:
97 
 591   Mmx mesalamine/mesalazine (low dose)   Mesalazine   D00377   -   -   1件:
97 
 592   Modified gegen qinlian decoction   -   -   -   -   1件:
97 
 593   Modified-release phosphatidylcholine   -   -   -   -   1件:
97 
 594   Mongersen   Mongersen   D10956   1件: SMAD7   2件: Hippo signaling pathway, TGF-beta signaling pathway   2件:
96,
97 
 595   Monoclonal antibody anti-igg1   -   -   -   -   3件:
37,
96,
97 
 596   Mtx 12.5   -   -   -   -   1件:
97 
 597   Mtx 25   -   -   -   -   1件:
97 
 598   Multiple dose- group b   -   -   -   -   1件:
97 
 599   Multiple dose-group b   -   -   -   -   1件:
97 
 600   Multistem high dose   -   -   -   -   1件:
97 
 601   Multistem low dose   -   -   -   -   1件:
97 
 602   Myrrh   Myrrh   D08948   -   -   1件:
97 
 603   Myrrhinil-intest®   -   -   -   -   1件:
97 
 604   N.a.   -   -   -   -   8件:
3,
6,
8,
13,
46,
97,
240,
256 
 605   Naltrexone   Naltrexone   D02095, D05113   3件: OPRD1, OPRK1, OPRM1   5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway   11件:
6,
10,
13,
40,
41,
42,
43,
44,
45,
96,
97 
 606   Nand (neoandrographolide)   -   -   -   -   1件:
97 
 607   Nanocort   -   -   -   -   3件:
13,
46,
97 
 608   Neomycin   Neomycin   D08260   -   -   3件:
96,
97,
296 
 609   Neoral   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   2件:
97,
222 
 610   Niclosamide   Niclosamide   D00436   -   -   2件:
46,
97 
 611   Nicolon   -   -   -   -   1件:
97 
 612   Nitazoxanide   Nitazoxanide   D02486   -   -   2件:
96,
97 
 613   Nitazoxanide 500mg oral tablet   Nitazoxanide   D02486   -   -   1件:
97 
 614   Nivolumab   Nivolumab   D10316   1件: PDCD1   3件: Cell adhesion molecules (CAMs), PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway   10件:
13,
26,
41,
46,
49,
50,
51,
53,
96,
97 
 615   Nolpitantium besylate   -   -   -   -   1件:
97 
 616   Non as of yet   -   -   -   -   1件:
97 
 617   Normal saline enema   -   -   -   -   1件:
97 
 618   Null   -   -   -   -   17件:
6,
13,
14,
15,
28,
37,
46,
49,
51,
63,
86,
90,
96,
97,
107,
145,
271 
 619   Nutrition supplement   -   -   -   -   1件:
97 
 620   Oats   -   -   -   -   1件:
97 
 621   Omeprazole   Omeprazole   D00455, D01207, D05259, D05261   2件: ATP4A, ATP4B   4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation   15件:
6,
8,
13,
46,
51,
85,
96,
97,
98,
225,
271,
282,
294,
298,
299 
 622   Opc-6535   -   -   -   -   2件:
96,
97 
 623   Opc-6535 tablets (drug)   -   -   -   -   1件:
97 
 624   Opc-6535(tetomilast)   Tetomilast   -   -   -   2件:
96,
97 
 625   Oprx-106   -   -   -   -   1件:
97 
 626   Oprx-106 (plant cells expressing tnfr-fc) 2mg   -   -   -   -   1件:
97 
 627   Oprx-106 (plant cells expressing tnfr-fc) 8mg   -   -   -   -   1件:
97 
 628   Oral 5-asa+/-topical 5-asa+iv corticosteroids / po methylprednisolone   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 629   Oral okt3   -   -   -   -   1件:
97 
 630   Ore1001   Ore1001   -   -   -   1件:
97 
 631   Orencia   Abatacept   D03203   2件: CD80, CD86   12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis   9件:
46,
50,
51,
53,
65,
84,
96,
97,
271 
 632   Originator (legacy) drug   -   -   -   -   4件:
46,
96,
97,
271 
 633   Overencapsulated azathioprine (imuran) 50 mg tablet   Azathioprine   D00238, D03033   -   -   1件:
97 
 634   Overencapsulated mesalazine tablets   Mesalazine   D00377   -   -   1件:
97 
 635   Oxygen   Oxygen   D00003   -   -   14件:
46,
49,
70,
84,
85,
86,
88,
90,
96,
97,
193,
226,
299,
330 
 636   Ozanimod   Ozanimod   D10968   5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5   3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   3件:
13,
96,
97 
 637   Ozanimod hydrochloride   Ozanimod   D10968   5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5   3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   3件:
13,
96,
97 
 638   Palmitoleic acid   Palmitoleic acid   -   -   -   1件:
97 
 639   Pancrelipase   Pancrelipase   D05349   -   -   4件:
96,
97,
298,
299 
 640   Parnaparin   Parnaparin   D07510   1件: SERPINC1   1件: Complement and coagulation cascades   1件:
97 
 641   Parnaparin sodium   Parnaparin   D07510   1件: SERPINC1   1件: Complement and coagulation cascades   1件:
97 
 642   Pbf-677   -   -   -   -   1件:
97 
 643   Pct (purecell technologies complex)   -   -   -   -   1件:
97 
 644   Peg-liposomal prednisolone sodium phosphate   Prednisolone   D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   2件:
13,
97 
 645   Pentasa   Mesalazine   D00377   -   -   1件:
97 
 646   Pentasa 2g sachet prolonged release granules (95%)   Mesalazine   D00377   -   -   1件:
97 
 647   Pentasa 500 mg retardtabletten   Mesalazine   D00377   -   -   1件:
97 
 648   Pentasa enema   Mesalazine   D00377   -   -   1件:
97 
 649   Pentasa prolonged release granules 2g   Mesalazine   D00377   -   -   1件:
97 
 650   Pentasa sachet 1g   Mesalazine   D00377   -   -   1件:
97 
 651   Pf 06687234   -   -   -   -   1件:
97 
 652   Pf-00547659 sc injection   -   -   -   -   2件:
96,
97 
 653   Pf-06480605   -   -   -   -   1件:
97 
 654   Pf-06651600   -   -   -   -   3件:
46,
96,
97 
 655   Pf-06687234   -   -   -   -   1件:
97 
 656   Pf-06700841   -   -   -   -   3件:
49,
96,
97 
 657   Pfefferminzblätter 1ml/10ml   -   -   -   -   1件:
97 
 658   Phosphate   Phosphate ion   -   -   -   29件:
2,
3,
11,
12,
13,
28,
36,
46,
49,
51,
53,
60,
62,
65,
70,
78,
81,
83,
90,
96,
97,
164,
235,
256,
283,
284,
285,
286,
299 
 659   Phosphatidylcholine   -   -   -   -   1件:
97 
 660   Photodynamic therapy with gliolan   -   -   -   -   1件:
97 
 661   Picosulfate   Picosulfuric acid   -   -   -   2件:
97,
291 
 662   Placebo   -   -   -   -   20件:
3,
6,
13,
14,
40,
46,
49,
50,
51,
66,
67,
79,
85,
86,
88,
96,
97,
144,
149,
226 
 663   Pn-10884a   -   -   -   -   1件:
97 
 664   Polaprezinc   Polaprezinc   D01611   -   -   2件:
96,
97 
 665   Polyethylene glycol   Polyethylene glycol   D03370   -   -   2件:
96,
97 
 666   Polyphenon e®   -   -   -   -   1件:
97 
 667   Pomegranate   Pomegranate   -   -   -   2件:
96,
97 
 668   Prd5973697   -   -   -   -   1件:
97 
 669   Prednisolon   -   -   -   -   4件:
46,
66,
96,
97 
 670   Prednisolon jenapharm   Acetylcysteine   D00221   -   -   2件:
96,
97 
 671   Prednisolone   Prednisolone   D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   38件:
11,
13,
25,
26,
35,
38,
39,
41,
43,
44,
45,
46,
49,
50,
51,
56,
60,
61,
63,
64,
65,
66,
75,
81,
84,
85,
95,
96,
97,
113,
145,
162,
222,
269,
271,
296,
299,
300 
 672   Prednisolone sodium metasulphobenzoate   Prednisolone   D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 673   Prednisolone sodium phosphate   Prednisolone   D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   2件:
13,
97 
 674   Prednisolone tablets b.p. 5mg   Prednisolone   D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 675   Prednisone   Prednisone   D00473   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   43件:
2,
11,
13,
14,
26,
35,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
61,
63,
64,
65,
66,
81,
84,
85,
86,
95,
96,
97,
113,
162,
164,
222,
224,
228,
251,
283,
284,
285,
288,
299,
300,
331 
 676   Pro145223 (ro5490261)   -   -   -   -   1件:
97 
 677   Probiotic mixture   -   -   -   -   2件:
96,
97 
 678   Probiotics   -   -   -   -   4件:
94,
96,
97,
291 
 679   Products containing aminosalicylate   -   -   -   -   1件:
97 
 680   Products containing azathioprine or 6-mercaptopurine   Mercaptopurine   D00161, D04931   1件: HPRT1   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   1件:
97 
 681   Proline   Proline   D00035   -   -   2件:
94,
97 
 682   Propionyl l-carnitine   Levocarnitine   D02030, D02176, D04713   -   -   1件:
97 
 683   Propionyl-l-carnitine   Levocarnitine   D02030, D02176, D04713   -   -   1件:
97 
 684   Prv-300   -   -   -   -   1件:
97 
 685   Ps-qd   -   -   -   -   1件:
97 
 686   Psyllium   Plantago seed   D05525   -   -   1件:
97 
 687   Psyllium husk   Plantago seed   D05525   -   -   1件:
97 
 688   Psyllium husk powder   Plantago seed   D05525   -   -   1件:
97 
 689   Ptg-100   -   -   -   -   1件:
97 
 690   Pur 0110   -   -   -   -   1件:
97 
 691   Pur 0110 rectal enema   -   -   -   -   1件:
97 
 692   Pur 0110 rectal enema 1000 mg   -   -   -   -   1件:
97 
 693   Pur 0110 rectal enema 250 mg   -   -   -   -   1件:
97 
 694   Pur 0110 rectal enema 500 mg   -   -   -   -   1件:
97 
 695   Qbeco ssi   -   -   -   -   1件:
97 
 696   Raspberry   Raspberry   -   -   -   1件:
97 
 697   Rdp58   -   -   -   -   1件:
97 
 698   Rebamipide   Rebamipide   D01121   -   -   4件:
46,
53,
97,
271 
 699   Recombinant factor xiii (rfxiii)   -   -   -   -   2件:
97,
288 
 700   Rectabul2mg rectal form   -   -   -   -   1件:
97 
 701   Rectal dialysis   -   -   -   -   1件:
97 
 702   Rectal tacrolimus   Tacrolimus   D00107, D08556   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   1件:
97 
 703   Regular treatment   -   -   -   -   1件:
97 
 704   Remicade   Infliximab   D02598   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   8件:
46,
49,
56,
84,
85,
96,
97,
271 
 705   Remsima   Infliximab   D02598   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   4件:
46,
96,
97,
271 
 706   Remsima (infliximab)   Infliximab   D02598   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   3件:
46,
96,
97 
 707   Remsima - 100 mg polvere per concentrato per soluzione per infusione - uso endovenoso - flanconcino (vetro) - 1 flaconcino   Infliximab   D02598   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   4件:
46,
96,
97,
271 
 708   Remsima and inflectra   Infliximab   D02598   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   2件:
96,
97 
 709   Retarded release phosphatidylcholine   -   -   -   -   1件:
97 
 710   Retarded release phosphatidylcholine (rpc)   -   -   -   -   1件:
97 
 711   Rhil-11   -   -   -   -   1件:
97 
 712   Rhumab beta7   -   -   -   -   1件:
97 
 713   Rhumab beta7, anti beta7, pro145223   -   -   -   -   1件:
97 
 714   Riboflavin   Riboflavin   D00050, D01622, D01913   -   -   8件:
13,
38,
46,
96,
97,
162,
168,
265 
 715   Rice   Rice   -   -   -   1件:
97 
 716   Rifaximin   Rifaximin   D02554   -   -   5件:
6,
96,
97,
99,
296 
 717   Risankizumab   Risankizumab   D11052   1件: IL23A   9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis   4件:
37,
96,
97,
271 
 718   Risankizumab (genetical recombination)   Risankizumab   D11052   1件: IL23A   9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis   1件:
97 
 719   Risankizumab iv   Risankizumab   D11052   1件: IL23A   9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis   2件:
96,
97 
 720   Risankizumab sc   Risankizumab   D11052   1件: IL23A   9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis   2件:
96,
97 
 721   Rituximab   Rituximab   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   42件:
11,
13,
14,
17,
35,
36,
43,
44,
45,
46,
49,
50,
51,
52,
53,
56,
60,
61,
63,
64,
65,
66,
83,
84,
85,
86,
93,
94,
96,
97,
162,
222,
223,
229,
256,
271,
283,
284,
285,
288,
300,
331 
 722   Rivenprost (drug)   -   -   -   -   1件:
97 
 723   Ro 549-0261/f04   -   -   -   -   1件:
97 
 724   Ro7049665   -   -   -   -   1件:
97 
 725   Ro7246311   -   -   -   -   1件:
97 
 726   Rosiglitazone   Rosiglitazone   D00596, D08491   1件: PPARG   9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer   5件:
46,
75,
97,
222,
265 
 727   Rpc1063   -   -   -   -   3件:
13,
96,
97 
 728   Salicylic acid   Salicylic acid   D00097   -   -   1件:
97 
 729   Saline   Sodium chloride   D02056   -   -   10件:
6,
13,
17,
53,
67,
78,
86,
97,
168,
299 
 730   Salofalk   Mesalazine   D00377   -   -   1件:
97 
 731   Salofalk 1000mg granu-stix   Mesalazine   D00377   -   -   1件:
97 
 732   Salofalk 4g/60ml klysma   Mesalazine   D00377   -   -   1件:
97 
 733   Salofalk granu-stix 500 mg   Mesalazine   D00377   -   -   1件:
97 
 734   Salofalk® 1000mg granu-stix®   -   -   -   -   1件:
97 
 735   Salofalk® 500 mg gastro-resistant tablet   -   -   -   -   1件:
97 
 736   Salofalk® 500 mg tablets   -   -   -   -   1件:
97 
 737   Salofalk® 500mg   -   -   -   -   1件:
97 
 738   Same   Ademetionine   D07128   -   -   15件:
6,
14,
22,
43,
44,
46,
47,
49,
50,
60,
84,
93,
96,
97,
172 
 739   Sandinum   -   -   -   -   1件:
97 
 740   Sar339658   -   -   -   -   2件:
13,
97 
 741   Sb-656933   -   -   -   -   1件:
97 
 742   Sb-656933 tablets   -   -   -   -   2件:
97,
299 
 743   Sb012   -   -   -   -   1件:
97 
 744   Sc12267   Sc12267   -   -   -   3件:
46,
96,
97 
 745   Sch 900050   -   -   -   -   1件:
97 
 746   Semi-vegetarian diet   -   -   -   -   1件:
97 
 747   Ser-287   -   -   -   -   1件:
97 
 748   Sf257 c59   -   -   -   -   1件:
97 
 749   Shingrix   -   -   -   -   3件:
46,
96,
97 
 750   Shp647   -   -   -   -   2件:
96,
97 
 751   Shr0302   -   -   -   -   3件:
46,
96,
97 
 752   Simponi   Golimumab   D04358   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   3件:
46,
97,
271 
 753   Simponi (golimumab)   Golimumab   D04358   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   1件:
97 
 754   Simponi® (golimumab)   Golimumab   D04358   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   1件:
97 
 755   Simulect   Basiliximab   D03058   1件: IL2RA   11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor   2件:
66,
97 
 756   Single dose-group a   -   -   -   -   1件:
97 
 757   Smoking cigarettes   -   -   -   -   2件:
96,
97 
 758   Smoking of cannabis   Medical cannabis   -   -   -   2件:
96,
97 
 759   Sodium hyaluronate   Hyaluronic acid   D08043   -   -   1件:
97 
 760   Sodium picosulfate/magnesium citrate laxative   Magnesium citrate   D03265   -   -   1件:
97 
 761   Solu-medrol   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   2件:
13,
97 
 762   Sotrastaurin   Sotrastaurin   D09671   4件: PRKCD, PRKCE, PRKCH, PRKCQ   26件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Aldosterone synthesis and secretion, Apelin signaling pathway, Autophagy - animal, C-type lectin receptor signaling pathway, Chemokine signaling pathway, Estrogen signaling pathway, Fc gamma R-mediated phagocytosis, GnRH signaling pathway, Inflammatory mediator regulation of TRP channels, Insulin resistance, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   1件:
97 
 763   Sotrastaurin (inn) acetate   Sotrastaurin   D09671   4件: PRKCD, PRKCE, PRKCH, PRKCQ   26件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Aldosterone synthesis and secretion, Apelin signaling pathway, Autophagy - animal, C-type lectin receptor signaling pathway, Chemokine signaling pathway, Estrogen signaling pathway, Fc gamma R-mediated phagocytosis, GnRH signaling pathway, Inflammatory mediator regulation of TRP channels, Insulin resistance, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   1件:
97 
 764   Soybean   Soybean   -   -   -   1件:
97 
 765   Soybean phosphatidylcholine   Soybean   -   -   -   1件:
97 
 766   Spd476   -   -   -   -   1件:
97 
 767   Spd476 is a polymeric matrix formulation that displays both delayed- and extended-release of mesalazine   Mesalazine   D00377   -   -   1件:
97 
 768   Spesolimab   -   -   -   -   3件:
37,
96,
97 
 769   Spesolimab iv infusion   -   -   -   -   1件:
97 
 770   Spesolimab sc solution for injection   -   -   -   -   1件:
97 
 771   Sr140333b   -   -   -   -   1件:
97 
 772   Srt2104   Srt2104   -   -   -   1件:
97 
 773   St 261   -   -   -   -   1件:
97 
 774   St-0529   -   -   -   -   1件:
97 
 775   St10-021   -   -   -   -   1件:
97 
 776   St261   -   -   -   -   1件:
97 
 777   Standard 2 hours-infusion   -   -   -   -   2件:
96,
97 
 778   Standard therapy   -   -   -   -   2件:
49,
97 
 779   Standardized anthocyanin-rich extract   -   -   -   -   1件:
97 
 780   Standardized fodmap   -   -   -   -   1件:
97 
 781   Sterile saline for injection   -   -   -   -   1件:
97 
 782   Steroids   -   -   -   -   7件:
46,
50,
51,
63,
66,
96,
97 
 783   Stnm01   -   -   -   -   1件:
97 
 784   Stnm01 1.84 mg   -   -   -   -   1件:
97 
 785   Stw5-ii   -   -   -   -   1件:
97 
 786   Sucrose   Sucrose   D00025   -   -   3件:
62,
96,
97 
 787   Sugar extract   -   -   -   -   2件:
96,
97 
 788   Sulphsalazine, pentasa, asacol, colazide, depentum   -   -   -   -   1件:
97 
 789   Suspension containing 7500 embryonated viable trichuris suis ova/15ml   -   -   -   -   1件:
97 
 790   Suspension de microbiote fécal   -   -   -   -   1件:
97 
 791   Synergy-1   -   -   -   -   1件:
97 
 792   Synergy1   -   -   -   -   1件:
97 
 793   Sübetaholzwurzel 1ml/10ml   -   -   -   -   1件:
97 
 794   Süßholzwurzel 1ml/10ml   -   -   -   -   1件:
97 
 795   Ta-650   -   -   -   -   4件:
37,
56,
96,
97 
 796   Ta-650 (infliximab)   Infliximab   D02598   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   3件:
46,
97,
271 
 797   Tacrolimus   Tacrolimus   D00107, D08556   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   29件:
2,
11,
13,
36,
46,
49,
50,
51,
53,
60,
61,
62,
65,
66,
85,
95,
96,
97,
113,
151,
158,
164,
222,
224,
226,
228,
283,
284,
299 
 798   Tauroursoursodeoxycholic acid, brand name tudcabil   -   -   -   -   1件:
97 
 799   Td-1473   -   -   -   -   2件:
96,
97 
 800   Td-1473 dose a   -   -   -   -   1件:
97 
 801   Td-1473 dose b   -   -   -   -   1件:
97 
 802   Td-1473 dose c   -   -   -   -   1件:
97 
 803   Td-3504   -   -   -   -   1件:
97 
 804   Telotristat   Telotristat   D09973   2件: TPH1, TPH2   4件: Folate biosynthesis, Metabolic pathways, Serotonergic synapse, Tryptophan metabolism   1件:
97 
 805   Telotristat etiprate   Telotristat   D09973   2件: TPH1, TPH2   4件: Folate biosynthesis, Metabolic pathways, Serotonergic synapse, Tryptophan metabolism   1件:
97 
 806   Terbinafine   Terbinafine   D02219, D02375   -   -   1件:
97 
 807   Tetomilast   Tetomilast   -   -   -   2件:
96,
97 
 808   Tetracycline   Tetracycline   D00201   -   -   4件:
13,
46,
53,
97 
 809   Thalidomide   Thalidomide   D00754   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   18件:
2,
16,
20,
28,
49,
51,
53,
65,
84,
85,
94,
96,
97,
227,
271,
280,
298,
331 
 810   Thalidomide pharmion   Thalidomide   D00754   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   3件:
85,
96,
97 
 811   Threonine   L-threonine   D00041   -   -   3件:
86,
96,
97 
 812   Thrx-139060   -   -   -   -   2件:
96,
97 
 813   Tj301 300mg   -   -   -   -   1件:
97 
 814   Tj301 600mg   -   -   -   -   1件:
97 
 815   Tofacitinib   Tofacitinib   D09970   4件: JAK1, JAK2, JAK3, TYK2   34件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis   9件:
46,
49,
50,
51,
84,
96,
97,
107,
271 
 816   Tofacitinib citrate (clinical trial image)   Tofacitinib   D09970   4件: JAK1, JAK2, JAK3, TYK2   34件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis   2件:
46,
97 
 817   Tofacitinib citrate (proposed commercial formulation – debossed)   Tofacitinib   D09970   4件: JAK1, JAK2, JAK3, TYK2   34件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis   1件:
97 
 818   Top1288   Top1288   -   -   -   1件:
97 
 819   Top1288 rectal solution   Top1288   -   -   -   1件:
97 
 820   Tp05   -   -   -   -   1件:
97 
 821   Tp05 coating a   -   -   -   -   1件:
97 
 822   Tp05 coating b   -   -   -   -   1件:
97 
 823   Tp05 coating d   -   -   -   -   1件:
97 
 824   Tp05 coating e   -   -   -   -   1件:
97 
 825   Tp05 coating h   -   -   -   -   1件:
97 
 826   Traditional treatments   -   -   -   -   1件:
97 
 827   Tralokinumab   Tralokinumab   D09979   1件: IL13   8件: Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease (IBD), JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation   2件:
85,
97 
 828   Trichuris suis eggs   -   -   -   -   3件:
13,
96,
97 
 829   Trichuris suis ova   -   -   -   -   4件:
13,
46,
96,
97 
 830   Trichuris suis ova (tso)   -   -   -   -   2件:
96,
97 
 831   Ucb4940   -   -   -   -   3件:
46,
97,
271 
 832   Ucmsc group   -   -   -   -   1件:
97 
 833   Udca   Ursodeoxycholic acid   D00734   1件: NR1H4   1件: Bile secretion   3件:
93,
94,
97 
 834   Umbilical cord mesenchymal stem cells   -   -   -   -   5件:
13,
46,
57,
97,
113 
 835   Upadacitinib   Upadacitinib   D10994   1件: JAK1   26件: EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis   6件:
41,
46,
49,
96,
97,
271 
 836   Upadacitinib (abt-494)   Upadacitinib   D10994   1件: JAK1   26件: EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis   1件:
97 
 837   Updacitinib (abt-494)   -   -   -   -   1件:
97 
 838   Ur-12746-s   -   -   -   -   1件:
97 
 839   Ursodeoxycholic acid   Ursodeoxycholic acid   D00734   1件: NR1H4   1件: Bile secretion   8件:
6,
67,
84,
93,
94,
95,
96,
97 
 840   Ursodiol   Ursodeoxycholic acid   D00734   1件: NR1H4   1件: Bile secretion   6件:
8,
20,
93,
97,
234,
299 
 841   Ursodiol (ursodeoxycholic acid, udca)   Ursodeoxycholic acid   D00734   1件: NR1H4   1件: Bile secretion   1件:
97 
 842   Ursofalk   Ursodeoxycholic acid   D00734   1件: NR1H4   1件: Bile secretion   4件:
93,
94,
96,
97 
 843   Ustekinumab   Ustekinumab   D09214   3件: IL12A, IL12B, IL23A   25件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease (IBD), Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus   15件:
37,
41,
46,
49,
50,
53,
56,
65,
84,
93,
96,
97,
162,
269,
271 
 844   Ustekinumab iv   Ustekinumab   D09214   3件: IL12A, IL12B, IL23A   25件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease (IBD), Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus   2件:
49,
97 
 845   Ustekinumab sc   Ustekinumab   D09214   3件: IL12A, IL12B, IL23A   25件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease (IBD), Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus   2件:
49,
97 
 846   Uttr1147a   -   -   -   -   2件:
96,
97 
 847   Uttr1147a, il22-fc, il-22fc   -   -   -   -   1件:
97 
 848   Uttr1147a/ro7021610 (active)   -   -   -   -   1件:
97 
 849   Vaccine vivotif + vaccine dukoral   -   -   -   -   1件:
97 
 850   Vaccine vivotif + vaccine dukoral + oats   -   -   -   -   1件:
97 
 851   Valganciclovir   Valganciclovir   D02495   -   -   6件:
28,
60,
85,
97,
299,
331 
 852   Vaminolac   -   -   -   -   1件:
97 
 853   Vaminolac, komb.   -   -   -   -   1件:
97 
 854   Vancomycin   Vancomycin   D00212, D00926   -   -   7件:
46,
70,
94,
96,
97,
296,
299 
 855   Vancomycin pre-treat   Vancomycin   D00212, D00926   -   -   1件:
97 
 856   Vancomycin pre-treatment   Vancomycin   D00212, D00926   -   -   1件:
97 
 857   Vb-201   -   -   -   -   1件:
97 
 858   Vb-201 160mg   -   -   -   -   1件:
97 
 859   Vedolizumab   Vedolizumab   D08083   2件: ITGA4, ITGB7   15件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection   2件:
96,
97 
 860   Vedolizumab 300 mg   Vedolizumab   D08083   2件: ITGA4, ITGB7   15件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection   1件:
97 
 861   Vedolizumab injection   Vedolizumab   D08083   2件: ITGA4, ITGB7   15件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection   1件:
97 
 862   Vedolizumab intravenous injection   Vedolizumab   D08083   2件: ITGA4, ITGB7   15件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection   2件:
96,
97 
 863   Vedolizumab iv   Vedolizumab   D08083   2件: ITGA4, ITGB7   15件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection   2件:
96,
97 
 864   Vedolizumab iv 300 mg   Vedolizumab   D08083   2件: ITGA4, ITGB7   15件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection   2件:
96,
97 
 865   Vedolizumab sc   Vedolizumab   D08083   2件: ITGA4, ITGB7   15件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection   2件:
96,
97 
 866   Vedolizumab sc 108 mg   Vedolizumab   D08083   2件: ITGA4, ITGB7   15件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection   2件:
96,
97 
 867   Vedolizumab subcutaneous injection   Vedolizumab   D08083   2件: ITGA4, ITGB7   15件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection   2件:
96,
97 
 868   Vidofludimus   Vidofludimus   -   -   -   2件:
94,
97 
 869   Vidofludimus calcium   Vidofludimus   -   -   -   2件:
94,
97 
 870   Vigantol oel   -   -   -   -   3件:
13,
96,
97 
 871   Vigantol oel tm   -   -   -   -   2件:
96,
97 
 872   Visilizumab   Visilizumab   D06314   3件: CD3D, CD3E, CD3G   11件: Chagas disease (American trypanosomiasis), Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   2件:
96,
97 
 873   Visilizumab (hum291   Visilizumab   D06314   3件: CD3D, CD3E, CD3G   11件: Chagas disease (American trypanosomiasis), Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   1件:
97 
 874   Visilizumab (nuvion)   Visilizumab   D06314   3件: CD3D, CD3E, CD3G   11件: Chagas disease (American trypanosomiasis), Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   1件:
97 
 875   Visilizumab (nuvion®   Visilizumab   D06314   3件: CD3D, CD3E, CD3G   11件: Chagas disease (American trypanosomiasis), Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   1件:
97 
 876   Vitamin b2   Riboflavin   D00050, D01622, D01913   -   -   1件:
97 
 877   Vitamin d3   Cholecalciferol   D00188   1件: VDR   4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   11件:
6,
13,
20,
46,
49,
53,
60,
65,
96,
97,
299 
 878   Vitamin e   Vitamin e   D02331   -   -   11件:
2,
6,
13,
20,
46,
90,
96,
97,
206,
299,
317 
 879   Vitamin e 800iu   Vitamin e   D02331   -   -   2件:
96,
97 
 880   Vsl#3   -   -   -   -   3件:
96,
97,
291 
 881   Vsl#3 (original de simone formulation)   -   -   -   -   2件:
96,
97 
 882   Vsl#3®   -   -   -   -   2件:
96,
97 
 883   Water   Water   D00001   -   -   18件:
2,
5,
6,
13,
17,
19,
35,
46,
53,
57,
63,
65,
67,
84,
97,
226,
278,
299 
 884   Wharton jelly mesenchymal stem cells   -   -   -   -   1件:
97 
 885   Xeljanz 5 mg film-coated tablets   -   -   -   -   1件:
97 
 886   Z-206   -   -   -   -   2件:
96,
97 
 887   Zoenasa-1:4   -   -   -   -   1件:
97 

先頭へ